GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p

BACKGROUND: Despite notable progression from a therapeutic point of view, castration resistant prostate cancer (CRPC) remains a clinical significant stumbling block. The current study aimed to elucidate the functional role of the gene glucocorticoid receptor (GR) in CRPC, and identify the contributi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linshen, Jiang, Hongjun, Zhang, Yufan, Wang, Chenrong, Xia, Xixi, Sun, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505006/
https://www.ncbi.nlm.nih.gov/pubmed/32568179
http://dx.doi.org/10.3233/CBM-191271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505006/
https://www.ncbi.nlm.nih.gov/pubmed/32568179
http://dx.doi.org/10.3233/CBM-191271

Ejemplares similares